These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 30913015

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
    Scully KJ, Brenner L, Martin K, Ruazol M, Sawicki GS, Uluer A, Neuringer I, Yonker LM, Sicilian L, Putman MS.
    Front Endocrinol (Lausanne); 2024; 15():1293709. PubMed ID: 38379863
    [Abstract] [Full Text] [Related]

  • 3. Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis.
    Tofé S, Moreno JC, Máiz L, Alonso M, Escobar H, Barrio R.
    Eur J Endocrinol; 2005 Feb; 152(2):241-7. PubMed ID: 15745932
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The utility of glucose area under the curve from the oral glucose tolerance test as a screening tool for cystic fibrosis-related diabetes.
    Gileles-Hillel A, Soesman LH, Miari S, Breuer O, Tsabari R, Elyashar-Earon H, Armoni S, Sprikkelman AB, Reiter J, Zangen D, Lavi E, Kerem E, Cohen-Cymberknoh M.
    Pediatr Pulmonol; 2022 Nov; 57(11):2774-2780. PubMed ID: 35999051
    [Abstract] [Full Text] [Related]

  • 9. Glucose intolerance in cystic fibrosis as a determinant of pulmonary function and clinical status.
    Lavie M, Fisher D, Vilozni D, Forschmidt R, Sarouk I, Kanety H, Hemi R, Efrati O, Modan-Moses D.
    Diabetes Res Clin Pract; 2015 Dec; 110(3):276-84. PubMed ID: 26508676
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characterization of patients with cystic fibrosis presenting an indeterminate glucose tolerance (INDET).
    Coriati A, Ziai S, Azar M, Berthiaume Y, Rabasa-Lhoret R.
    J Cyst Fibros; 2016 Jan; 15(1):127-32. PubMed ID: 25818059
    [Abstract] [Full Text] [Related]

  • 12. Disposition index identifies defective beta-cell function in cystic fibrosis subjects with normal glucose tolerance.
    Merjaneh L, He Q, Long Q, Phillips LS, Stecenko AA.
    J Cyst Fibros; 2015 Jan; 14(1):135-41. PubMed ID: 24998161
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Peak glucose during an oral glucose tolerance test is associated with future diabetes risk in adults with cystic fibrosis.
    Bonhoure A, Potter KJ, Colomba J, Boudreau V, Bergeron C, Desjardins K, Carricart M, Tremblay F, Lavoie A, Rabasa-Lhoret R.
    Diabetologia; 2021 Jun; 64(6):1332-1341. PubMed ID: 33693987
    [Abstract] [Full Text] [Related]

  • 16. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
    Piechowiak K, Trippenbach-Dulska H, Walicka-Serzysko K.
    Dev Period Med; 2015 Jun; 19(1):80-91. PubMed ID: 26003073
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Use of hemoglobin A1c to identify dysglycemia in cystic fibrosis.
    Darukhanavala A, Van Dessel F, Ho J, Hansen M, Kremer T, Alfego D.
    PLoS One; 2021 Jun; 16(4):e0250036. PubMed ID: 33882078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.